Pre-order Enquiry
Request Free Sample
Global Nuclear Medicine & Radiopharmaceuticals Market outlook 2021
SKU ID : QYR-17039381 | Publishing Date : 21-Dec-2020 | No. of pages : 115
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Nuclear Medicine & Radiopharmaceuticals Market outlook 2021
1 Nuclear Medicine & Radiopharmaceuticals Market Overview1.1 Product Overview and Scope of Nuclear Medicine & Radiopharmaceuticals
1.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type
1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Nuclear Medicine & Radiopharmaceuticals Segment by Application
1.3.1 Nuclear Medicine & Radiopharmaceuticals Sales Comparison by Application: (2020-2026)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Nuclear Medicine & Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue 2015-2026
1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Sales 2015-2026
1.4.3 Nuclear Medicine & Radiopharmaceuticals Market Size by Region: 2020 Versus 2026
2 Global Nuclear Medicine & Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
2.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Nuclear Medicine & Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 Nuclear Medicine & Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 Nuclear Medicine & Radiopharmaceuticals Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Nuclear Medicine & Radiopharmaceuticals Players (Opinion Leaders)
3 Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario by Region
3.1 Global Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
3.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country
3.3.2 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country
3.4.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region
3.5.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country
3.6.2 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country
3.7.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Analysis by Type
4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2015-2020)
4.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
4.3 Global Nuclear Medicine & Radiopharmaceuticals Price Market Share by Type (2015-2020)
4.4 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Analysis by Application
5.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2015-2020)
5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
5.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2015-2020)
6 Company Profiles and Key Figures in Nuclear Medicine & Radiopharmaceuticals Business
6.1 Bracco Imaging
6.1.1 Corporation Information
6.1.2 Bracco Imaging Description, Business Overview
6.1.3 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Bracco Imaging Products Offered
6.1.5 Bracco Imaging Recent Development
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description, Business Overview
6.2.3 Bayer Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Bayer Products Offered
6.2.5 Bayer Recent Development
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description, Business Overview
6.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Mallinckrodt Products Offered
6.3.5 Mallinckrodt Recent Development
6.4 Nordion
6.4.1 Nordion Corporation Information
6.4.2 Nordion Description, Business Overview
6.4.3 Nordion Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Nordion Products Offered
6.4.5 Nordion Recent Development
6.5 Triad Isotopes
6.5.1 Triad Isotopes Corporation Information
6.5.2 Triad Isotopes Description, Business Overview
6.5.3 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Triad Isotopes Products Offered
6.5.5 Triad Isotopes Recent Development
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description, Business Overview
6.6.3 Lantheus Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Lantheus Products Offered
6.6.5 Lantheus Recent Development
6.7 IBA Group
6.6.1 IBA Group Corporation Information
6.6.2 IBA Group Description, Business Overview
6.6.3 IBA Group Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.4.4 IBA Group Products Offered
6.7.5 IBA Group Recent Development
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Description, Business Overview
6.8.3 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.8.4 GE Healthcare Products Offered
6.8.5 GE Healthcare Recent Development
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Corporation Information
6.9.2 China Isotope & Radiation Description, Business Overview
6.9.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.9.4 China Isotope & Radiation Products Offered
6.9.5 China Isotope & Radiation Recent Development
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Corporation Information
6.10.2 Jubilant Pharma Description, Business Overview
6.10.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Jubilant Pharma Products Offered
6.10.5 Jubilant Pharma Recent Development
6.11 Eli Lilly
6.11.1 Eli Lilly Corporation Information
6.11.2 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Description, Business Overview
6.11.3 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Eli Lilly Products Offered
6.11.5 Eli Lilly Recent Development
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Corporation Information
6.12.2 Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Description, Business Overview
6.12.3 Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Advanced Accelerator Applications Products Offered
6.12.5 Advanced Accelerator Applications Recent Development
6.13 SIEMENS
6.13.1 SIEMENS Corporation Information
6.13.2 SIEMENS Nuclear Medicine & Radiopharmaceuticals Description, Business Overview
6.13.3 SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.13.4 SIEMENS Products Offered
6.13.5 SIEMENS Recent Development
6.14 Dongcheng
6.14.1 Dongcheng Corporation Information
6.14.2 Dongcheng Nuclear Medicine & Radiopharmaceuticals Description, Business Overview
6.14.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Dongcheng Products Offered
6.14.5 Dongcheng Recent Development
6.15 Navidea
6.15.1 Navidea Corporation Information
6.15.2 Navidea Nuclear Medicine & Radiopharmaceuticals Description, Business Overview
6.15.3 Navidea Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Navidea Products Offered
6.15.5 Navidea Recent Development
7 Nuclear Medicine & Radiopharmaceuticals Manufacturing Cost Analysis
7.1 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
7.4 Nuclear Medicine & Radiopharmaceuticals Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nuclear Medicine & Radiopharmaceuticals Distributors List
8.3 Nuclear Medicine & Radiopharmaceuticals Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Nuclear Medicine & Radiopharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nuclear Medicine & Radiopharmaceuticals by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Nuclear Medicine & Radiopharmaceuticals by Type (2021-2026)
10.2 Nuclear Medicine & Radiopharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nuclear Medicine & Radiopharmaceuticals by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Nuclear Medicine & Radiopharmaceuticals by Application (2021-2026)
10.3 Nuclear Medicine & Radiopharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nuclear Medicine & Radiopharmaceuticals by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Nuclear Medicine & Radiopharmaceuticals by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Nuclear Medicine & Radiopharmaceuticals Market outlook 2021
List of TablesTable 1. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Nuclear Medicine & Radiopharmaceuticals Manufacturers Covered in This Study
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Nuclear Medicine & Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Nuclear Medicine & Radiopharmaceuticals Sales Sites and Area Served
Table 11. Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Types
Table 12. Global Nuclear Medicine & Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nuclear Medicine & Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine & Radiopharmaceuticals as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Nuclear Medicine & Radiopharmaceuticals Players
Table 16. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Region (2015-2020)
Table 17. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 18. Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) by Region (2015-2020)
Table 19. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 20. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 21. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 22. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 24. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 25. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 26. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 32. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 33. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 34. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 40. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 41. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 42. Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) by Type (2015-2020)
Table 43. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 44. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Type (2015-2020)
Table 45. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 46. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 47. Global Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate by Application (2015-2020)
Table 48. Bracco Imaging Corporation Information
Table 49. Bracco Imaging Description and Business Overview
Table 50. Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Bracco Imaging Main Product
Table 52. Bracco Imaging Recent Development
Table 53. Bayer Corporation Information
Table 54. Bayer Description and Business Overview
Table 55. Bayer Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Bayer Main Product
Table 57. Bayer Recent Development
Table 58. Mallinckrodt Corporation Information
Table 59. Mallinckrodt Description and Business Overview
Table 60. Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Mallinckrodt Main Product
Table 62. Mallinckrodt Recent Development
Table 63. Nordion Corporation Information
Table 64. Nordion Description and Business Overview
Table 65. Nordion Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Nordion Main Product
Table 67. Nordion Recent Development
Table 68. Triad Isotopes Corporation Information
Table 69. Triad Isotopes Description and Business Overview
Table 70. Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Triad Isotopes Main Product
Table 72. Triad Isotopes Recent Development
Table 73. Lantheus Corporation Information
Table 74. Lantheus Description and Business Overview
Table 75. Lantheus Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Lantheus Main Product
Table 77. Lantheus Recent Development
Table 78. IBA Group Corporation Information
Table 79. IBA Group Description and Business Overview
Table 80. IBA Group Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. IBA Group Main Product
Table 82. IBA Group Recent Development
Table 83. GE Healthcare Corporation Information
Table 84. GE Healthcare Description and Business Overview
Table 85. GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. GE Healthcare Main Product
Table 87. GE Healthcare Recent Development
Table 88. China Isotope & Radiation Corporation Information
Table 89. China Isotope & Radiation Description and Business Overview
Table 90. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. China Isotope & Radiation Main Product
Table 92. China Isotope & Radiation Recent Development
Table 93. Jubilant Pharma Corporation Information
Table 94. Jubilant Pharma Description and Business Overview
Table 95. Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Jubilant Pharma Main Product
Table 97. Jubilant Pharma Recent Development
Table 98. Eli Lilly Corporation Information
Table 99. Eli Lilly Description and Business Overview
Table 100. Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Eli Lilly Main Product
Table 102. Eli Lilly Recent Development
Table 103. Advanced Accelerator Applications Corporation Information
Table 104. Advanced Accelerator Applications Description and Business Overview
Table 105. Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Advanced Accelerator Applications Main Product
Table 107. Advanced Accelerator Applications Recent Development
Table 108. SIEMENS Corporation Information
Table 109. SIEMENS Description and Business Overview
Table 110. SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. SIEMENS Main Product
Table 112. SIEMENS Recent Development
Table 113. Dongcheng Corporation Information
Table 114. Dongcheng Description and Business Overview
Table 115. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Dongcheng Main Product
Table 117. Dongcheng Recent Development
Table 118. Navidea Corporation Information
Table 119. Navidea Description and Business Overview
Table 120. Navidea Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Navidea Main Product
Table 122. Navidea Recent Development
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Nuclear Medicine & Radiopharmaceuticals Distributors List
Table 126. Nuclear Medicine & Radiopharmaceuticals Customers List
Table 127. Nuclear Medicine & Radiopharmaceuticals Market Trends
Table 128. Nuclear Medicine & Radiopharmaceuticals Opportunities and Drivers
Table 129. Nuclear Medicine & Radiopharmaceuticals Market Challenges
Table 130. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Forecast by Type (2021-2026)
Table 131. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2026)
Table 132. Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) Forecast by Type (2021-2026)
Table 133. Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 134. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Forecast by Application (2021-2026)
Table 135. Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) Forecast by Application (2021-2026)
Table 136. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Forecast by Region (2021-2026)
Table 137. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Region (2021-2026)
Table 138. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Region (2021-2026)
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Nuclear Medicine & Radiopharmaceuticals
Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type: 2020 VS 2026
Figure 3. Diagnostic Radioisotopes Product Picture
Figure 4. Therapeutic Radioisotopes Product Picture
Figure 5. Global Nuclear Medicine & Radiopharmaceuticals Consumption Market Share by Application: 2020 VS 2026
Figure 6. Oncology
Figure 7. Cardiology
Figure 8. Other
Figure 9. Global Nuclear Medicine & Radiopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 10. Global Nuclear Medicine & Radiopharmaceuticals Sales Capacity (K Units) (2015-2026)
Figure 11. Global Nuclear Medicine & Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturers in 2020
Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine & Radiopharmaceuticals Revenue in 2019
Figure 15. Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Figure 17. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 19. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 20. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 21. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 22. U.S. Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 27. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 28. Germany Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 39. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 40. China Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 63. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 64. Mexico Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 72. Turkey Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Nuclear Medicine & Radiopharmaceuticals by Type (2015-2020)
Figure 79. Sales Market Share of Nuclear Medicine & Radiopharmaceuticals by Type in 2020
Figure 80. Global Nuclear Medicine & Radiopharmaceuticals Market Share by Price Range (2015-2020)
Figure 81. Revenue Market Share of Nuclear Medicine & Radiopharmaceuticals by Type in 2019
Figure 82. Global Nuclear Medicine & Radiopharmaceuticals Sales Growth by Type (2015-2020) (K Units)
Figure 83. Sales Market Share of Nuclear Medicine & Radiopharmaceuticals by Application (2015-2020)
Figure 84. Sales Market Share of Nuclear Medicine & Radiopharmaceuticals by Application in 2020
Figure 85. Revenue Share of Nuclear Medicine & Radiopharmaceuticals by Application (2015-2020)
Figure 86. Revenue Share of Nuclear Medicine & Radiopharmaceuticals by Application in 2020
Figure 87. Key Raw Materials Price Trend
Figure 88. Manufacturing Cost Structure of Nuclear Medicine & Radiopharmaceuticals
Figure 89. Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
Figure 90. Nuclear Medicine & Radiopharmaceuticals Industrial Chain Analysis
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Porter's Five Forces Analysis
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
Keyplayers in Global Nuclear Medicine & Radiopharmaceuticals Market outlook 2021
Bracco ImagingBayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
